In cancers which retain a wild-type p53 (wt p53) expression, the most important negative regulator of p53, mouse-double-minute 2 (MDM2 or HDM2, the human equivalent), is often overexpressed or amplified [18]. This evidence concerns the gene MDM2 and cancer.